Build an AI Longitudinal Lab-Tracking and Dosing-Support Tool

A clinical-support software tool for hormone clinics. It ingests each patient's hormone lab results over time, tracks the trends, and automates the reassessment cadence the guidelines call for: it schedules and flags every patient due for their 3-to-6-month reassessment, and surfaces longitudinal data so the clinician can adjust dosing on evidence rather than guesswork. It supports the clinician's judgment and never replaces it. It sells into a documented, category-wide failure mode as a recurring-revenue product.

It automates the fix for a documented failure. Inconsistent follow-up and lab monitoring is one of the most-cited reasons hormone practices fail, and the reassessment cadence (every 3 to 6 months in the first year) is explicitly recommended by the Endocrine Society and the North American Menopause Society. A tool that flags who is due and tracks trends closes that compliance gap automatically, protecting the retention (75 to 88 percent) that drives the whole model's economics. Because every hormone clinic faces the same monitoring requirement, one product serves the category at software margins of 60 to 80 percent. Better monitoring also directly counters the negative word-of-mouth that scares patients off. All figures vary by clinic, and the tool is decision support, not medical advice.

The failure looks like a staff-discipline issue, so people try to fix it with reminders and willpower rather than software, and it keeps recurring. Yet it is a clinically documented, guideline-backed cadence that is perfectly suited to automation: flag who is due, track the trend, surface it to the clinician. Builders also shy away because it touches patient data and dosing, which raises the compliance bar, but that bar is exactly what keeps the space open for a serious operator. Automating a guideline-recommended reassessment is a defensible, category-wide need hiding behind a discipline framing.